Position in BNTX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$706,418
-$117,552 QoQ
Shares Held
7,948
-4.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in BNTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $706,418 | 7,948 | Shares | Sole | 2026-05-04 | |
| 2025-09-30 | $823,970 | 8,355 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,125,387 | 10,570 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $797,867 | 8,762 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,333,354 | 20,477 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,488,587 | 20,953 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $9,738,105 | 121,181 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $12,023,957 | 130,341 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,054,770 | 123,695 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,453,711 | 13,381 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,719,109 | 15,928 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,530,549 | 972,535 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,944,762 | 19,603 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,623,416 | 19,450 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,192,962 | 14,708 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $2,224,102 | 13,040 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $6,532,136 | 25,338 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $4,858,130 | 17,796 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $3,224,991 | 14,405 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $728,734 | 6,674 | Shares | Sole | 2021-05-04 | |
| No filing history on record for this holder in this stock. | ||||||